The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.
Jackie supports the Herman B Wells Center for Pediatric Research at IU School of Medicine. As communications generalist, Jackie helps spread the word about the Wells Center's commitment to improving the health of children in Indiana and beyond through basic and translational research. She has several years of experience in non-profit and academic marketing and communications.
In October 2023, Andrea Conroy, PhD, an assistant professor of pediatrics at Indiana University School of Medicine was honored with the prestigious Bailey K. Ashford Medal by the American Society of Tropical Medicine and Hygiene (ASTMH). This accolade celebrates her distinguished contributions to the field of tropical medicine.
In March 2023, 10-year-old Emmaline Swigert was diagnosed with type 1 diabetes, an autoimmune disease where the body’s immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. Today, Emmaline is participating in an Indiana University School of Medicine-led clinical trial aimed at testing a pill that could help make life much easier for individuals like her living with the condition.
In a recently published Pediatrics clinical report, the American Academy of Pediatrics (AAP) represented by Indiana University School of Medicine professor of pediatrics Tamara Hannon, MD, examined the suitability of low-carb diets for children and adolescents with type 1 diabetes or those who are overweight and susceptible to type 2 diabetes.
In August 2023, a Riley Hospital for Children patient became the first child in Indiana to receive teplizumab, a groundbreaking therapy that delays the onset of stage 3 type 1 diabetes by an average of three years. The treatment received Federal Drug Administration approval in November 2022, three years after Indiana University School of Medicine researchers conducted clinical trials and published data that helped lead to the FDA’s decision.
The Wells Center for Pediatric Research has recognized several researchers with awards during their spring 2023 round of funding to support five promising projects focused on emerging therapies and clinical and translational pediatric research.
In a study published in Blood, researchers from Indiana University School of Medicine shed new light on the underlying causes of negative immune responses to factor VIII treatments, providing valuable insights that could lead to more effective and safer hemophilia A treatments in the future.
Seven scientists from IU School of Medicine have been recognized with 2023 Pilot and Feasibility (P&F) Awards from the Center for Diabetes and Metabolic Diseases (CDMD) at Indiana University School of Medicine, an NIDDK-designated Diabetes Research Center.